Andrew K Balo
CIK 1323190 · EVP Regulatory Strategy Clinic · last filed 2025-10-07
Andrew K Balo is an EVP Regulatory Strategy Clinic who has filed 122 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for GCTK, was dated Oct 7, 2025. Across all open-market trades the lifetime net is −$65.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.75M
2
122
-$65.05M
Holdings By Company
Recent Filings
122 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-07 | GCTK | Grant (A) | +4,692 | $0 | EDGAR |
| 2025-03-28 | GCTK | Grant (A) | +4,490 | $0 | EDGAR |
| 2023-03-14 | DXCM | Disp (D) | −11,670 | -$1.30M | EDGAR |
| 2022-03-10 | DXCM | Mixed | +1,554 | -$1.39M | EDGAR |
| 2021-09-13 | DXCM | Mixed | −5,597 | -$3.06M | EDGAR |
| 2021-08-04 | DXCM | Sell (S) | −2,757 | -$1.42M | EDGAR |
| 2021-07-08 | DXCM | Sell (S) | −2,974 | -$1.28M | EDGAR |
| 2021-06-07 | DXCM | Mixed | −2,391 | -$896.6K | EDGAR |
| 2021-03-12 | DXCM | Sell (S) | −5,566 | -$2.02M | EDGAR |
| 2021-03-10 | DXCM | Grant (A) | +5,301 | $5 | EDGAR |